Quick Takeaways
- Arvind Kush has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $198,650.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Arvind Kush
- Location
- San Diego, CA
- Summary
- The estimated net worth of Arvind Kush is at least $198,650 dollars as of 02 Jul 2025. Arvind Kush is the Director of Inhibikase Therapeutics, Inc. and owns shares of Inhibikase Therapeutics, Inc. (IKT) stock worth about $198.6K.
- Signature
- /s/ David McIntyre, attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Arvind Kush and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Inhibikase Therapeutics, Inc. ($198,650).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Arvind Kush
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| IKT | Inhibikase Therapeutics, Inc. | Director | $198,650 | 30 Jun 2025 | ||
| RYZB | RayzeBio, Inc. | Chief Financial Officer | $0 | 26 Feb 2024 |
Insider Transactions Reported by Arvind Kush:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.